Chromosome instability and risk of squamous cell carcinomas of head and neck

Cancer Research

Volumn 68, Issue 11, 2008, Pages 4479-4485

  Wang, Li E ^a   Xiong, Ping ^a   Zhao, Hui ^a   Spitz, Margaret R ^a   Sturgis, Erich M ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYBENZO[A]PYRENE OXIDE; MUTAGENIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CELL CULTURE; CHROMATID; CHROMOSOMAL INSTABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRINKING; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNICITY; FEMALE; GENETIC VARIABILITY; HEAD AND NECK CARCINOMA; HISPANIC; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; METAPHASE; PRIORITY JOURNAL; RISK FACTOR; SEX; SMOKING; SQUAMOUS CELL CARCINOMA; VALIDATION STUDY; ADOLESCENT; CASE CONTROL STUDY; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOMAL INSTABILITY; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 49249130574     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6568     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7.
3. Gelboin HV. Benzo[α]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 1980;60:1107-66.
4. Wei Q, Gu J, Cheng L, et al. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res 1996;56:3975-9.
5. de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000;21:453-60.
6. Li D, Wang M, Cheng L, Spitz MR, Hittelman WN, Wei Q. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res 1996;56:3638-41.
7. Wei Q, Cheng L, Amos CI, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92:1764-72.
8. Li D, Firozi PF, Wang LE, et al. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res 2001;61:1445-50.
9. Wang LE, Sturgis EM, Eicher SA, Spitz MR, Hong WK, Wei Q. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 1998;4:1773-8.
10. Li D, Firozi PF, Chang P, et al. In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. Int J Cancer 2001;93:436-40.
11. Li D, Wang LE, Chang P, El-Naggar AK, Sturgis EM, Wei Q. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck. Cancer Res 2007;67:5628-34.
12. Cherry LM, Hsu TC. Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members. Anticancer Res 1983;3:367-72.
13. Spitz MR, Fueger JJ, Beddingfield NA, et al. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 1989;49:4626-8.
14. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 1995;4:99-103.
15. Cloos J, Spitz MR, Schantz SP, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:530-5.
16. Fireman Z, Shabtai F, Lurie B. Chromosome sensitivity to bleomycin-induced mutagenesis in lymphocytes from colorectal cancer patients under 40 years of age. Dis Colon Rectum 1994;37:1317-20.
17. Ankathil R, Jyothish B, Madhavan J, Nair MK. Deficient DNA repair capacity: a predisposing factor and high risk predictive marker in familial colorectal cancer. J Exp Clin Cancer Res 1999;18:33-7.
18. Wu X, Lippman SM, Lee JJ, et al. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res 2002;62:2813-8.
19. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
20. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994;12:851-73.
21. Cloos J, Reid CB, van der Sterre ML, et al. A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects. Mutagenesis 1999;14:87-93.
22. Bondy ML, Wang LE, El-Zein R, et al. γ-radiation sensitivity and risk of glioma. J Natl Cancer Inst 2001;93:1553-7.
23. Bondy ML, Kyritsis AP, Gu J, et al. Mutagen sensitivity and risk of gliomas: a case-control analysis. Cancer Res 1996;56:1484-6.
24. Wang LE, Xiong P, Strom SS, et al. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst 2005;97:1822-31.
25. Wang LE, Hsu TC, Xiong P, et al. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of non-melanoma skin cancer: a case-control analysis. J Invest Dermatol 2007;127:196-205.
26. Wu X, Spitz MR, Amos CI, et al. Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res 2006;66:5993-6.
27. Cloos J, Braakhuis BJ, Steen I, et al. Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 1994;56:816-9.
28. Cloos J, Snow GB, Braakhuis BJ. Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability. Laryngorhinootologie 1995;74:742-7.
29. Wu X, Gu J, Spitz MR. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res 2007;67:3493-5.
30. Schroeder TM. Genetically determined chromosome instability syndromes. Cytogenet Cell Genet 1982;33:119-32.
31. Taylor AM. Chromosome instability syndromes. Best Pract Res Clin Haematol 2001;14:631-44.
32. Duker NJ. Chromosome breakage syndromes and cancer. Am J Med Genet 2002;115:125-9.
33. Mechanic LE, Millikan RC, Player J, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 2006;27:1377-85.
34. Lin J, Swan GE, Shields PG, et al. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev 2007;16:2065-71.